Patient & Visitor InformationContact Us
  • Genitourinary Protocols

  • Renal Cell

    1. LS-P-Argos: An International Phase 3, Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS-003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)
      PI: Jodi Layton, MD
      Sites: The Miriam Hospital
      Learn more about this study